Funding news
Heidi logo

Heidi Secures $65M Series B to Expand AI Clinical Capacity

Recently funded · $65 Series bHospitals and Health Care

Get the full Heidi company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Heidi, the AI Care Partner designed to expand clinical capacity, has secured $65 million in new funding from investors. This significant capital injection reinforces the company's mission to automate administrative work for healthcare professionals, enabling them to dedicate more focused time to patient care.

The Melbourne, Australia-founded company specializes in streamlining tasks such as documentation, form filling, and task management using artificial intelligence. Heidi's AI-powered platform is currently deployed across diverse healthcare settings, including emergency departments, general practices, and specialist clinics. Its technology is instrumental in supporting over 2 million consults each week, serving clinicians and patients in 110 languages across 116 countries, demonstrating its global reach and impact.

This latest investment round underscores the growing demand for intelligent solutions that effectively address healthcare's operational challenges and help mitigate clinician burnout. The newly raised capital will be strategically deployed to accelerate Heidi's growth initiatives, which include further research and development into its advanced AI capabilities and expanding its market footprint globally. The company's commitment to robust data privacy and security, evidenced by its adherence to international standards like NHS, HIPAA, GDPR, and Australian Privacy Principles, along with enterprise-grade security certifications such as SOC2 and ISO27001, provides a strong foundation for its continued expansion and instills confidence among its stakeholders and investors.

Looking ahead, Heidi aims to solidify its position as a leading AI Care Partner, further enhancing clinical efficiency and patient outcomes on a global scale. The company remains dedicated to innovating its platform to meet the evolving needs of the healthcare sector, driving transformative change in how administrative burdens are managed and supporting clinicians worldwide.

Other recently funded companies

View all

Other recent Series b rounds

Companies that recently closed a Series b round.

#CompanyAmount
1
Isomorphic Labs logo

Isomorphic Labs

United Kingdom

$2.1B
2
Invert Robotics logo

Invert Robotics

Ireland

$2.7M
3
Catch Co. logo

Catch Co.

United States

$38.0M
4
Tarsus Pharmaceuticals, Inc. logo

Tarsus Pharmaceuticals, Inc.

United States

$60.0M
5
Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

United States

$21.0M